EU antitrust regulators

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources

EU antitrust regulators will open an extensive probe into Zimmer's (ZMH.N) $13.4 billion bid for Biomet, concerned that the creation of the world's second-largest orthopedic products group may hurt competition, three people familiar with the matter said on Thursday.

Read Full Article

EU objections to Universal/EMI deal in coming days -source

EU antitrust regulators are expected to set out their objections to Universal Music Group's $1.9 billion bid for rival EMI's recorded music unit in the coming days.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics